Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision history shows a new revision label (v3.4.2) replacing the previous v3.4.1; this is a cosmetic update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedA new revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedUI updates on the record history page add a glossary toggle, emphasize changes with green/red highlights, and show revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check53 days agoChange DetectedA new page revision was added to the history: v3.3.4, replacing the prior revision v3.3.3. To avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.SummaryDifference0.2%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.